Enhance your knowledge with our comprehensive guide and curated study materials.
Liver function tests evaluate synthetic capacity, excretory function, detoxification, and liver cell integrity.
ALT (Alanine transaminase)
More specific for liver damage
Markedly elevated in viral hepatitis
AST (Aspartate transaminase)
Also elevated in muscle injury
AST:ALT >2 → Alcoholic hepatitis
LDH-5 (liver component) increases in hepatic injury.
Raised in biliary obstruction
Also high in bone disease → check GGT to confirm liver cause
High in alcohol intake and cholestasis
Helps differentiate hepatic ALP from bone ALP
Low in chronic liver disease
Normal in acute hepatitis (long half-life ~21 days)
Prolonged in:
Acute liver failure
Vitamin K deficiency
Cholestasis (poor vitamin K absorption)
Low in severe liver disease
High in obstructive jaundice (due to impaired excretion)
Assesses conjugation + excretion.
Urine bilirubin positive → conjugated hyperbilirubinemia
Urine urobilinogen high → hemolysis
Urine urobilinogen absent → obstructive jaundice
Increased in hepatic failure, hepatic encephalopathy
Bilirubin is produced from heme breakdown.
Water-insoluble
Albumin-bound
Formed in spleen
Increased in:
Hemolysis
Gilbert syndrome
Crigler-Najjar
Neonatal jaundice
Water-soluble
Conjugated by UDP-glucuronyl transferase
Increased in:
Hepatocellular disease
Obstructive jaundice
Dubin-Johnson
Rotor syndrome
Total: 0.3–1.2 mg/dL
Direct: 0.1–0.3 mg/dL
Indirect: subtract direct from total
(Based on site of defect)
Hemolysis (G6PD deficiency, thalassemia, malaria)
↑ Unconjugated bilirubin
Normal direct bilirubin
↑ Urobilinogen
No urine bilirubin
Normal ALP/ALT
Urine bilirubin: absent
Urobilinogen: increased
Viral hepatitis
Alcoholic hepatitis
Drug-induced liver injury
Cirrhosis
↑ Both unconjugated + conjugated bilirubin
↑ ALT >> AST or AST >> ALT
Moderate ALP elevation
↓ Albumin (chronic)
Prolonged PT (vitamin K deficiency)
Urine bilirubin: present
Urobilinogen: variable
Gallstones
Carcinoma head of pancreas
Biliary stricture
Primary sclerosing cholangitis
↑ Conjugated bilirubin
Very high ALP
High GGT
Cholesterol ↑
Pale stools (no stercobilin)
Dark urine (bilirubin present)
Urine bilirubin: present
Urobilinogen: absent
Produced in liver from cholesterol.
Cholic acid
Chenodeoxycholic acid
(Produced by gut bacteria)
Deoxycholic acid
Lithocholic acid
Bile acids conjugated with:
Glycine
Taurine
→ form bile salts (better solubility, detergent action)
Examples:
Glycocholate
Taurocholate
Emulsify dietary fats
Increase surface area → pancreatic lipase action
Solubilize monoglycerides + fatty acids + fat-soluble vitamins
Route for excretion of bilirubin, cholesterol, drugs
Inhibit HMG-CoA reductase
Control bile acid synthesis by feedback
ALT is most specific for liver injury.
ALP + GGT rise sharply in obstruction.
Conjugated bilirubin in urine = hepatocellular or obstructive jaundice.
Hemolytic jaundice = ↑ indirect bilirubin + ↑ urobilinogen.
Obstructive jaundice = ↑ direct bilirubin + no urobilinogen + pale stool.
Bile salts are conjugated bile acids → essential for fat digestion.
These tests assess how well the liver performs biotransformation, detoxification, and metabolic reactions.
Liver converts galactose → glucose.
If hepatic metabolism is impaired, conversion is delayed.
High blood galactose after oral load → impaired hepatic metabolism
Seen in:
Hepatocellular dysfunction
Cirrhosis
Acute hepatitis
Similar to galactose test.
Delayed clearance of fructose → reduced hepatic metabolic ability.
(Rarely used today.)
A classic test (historical but high-yield).
BSP dye is taken up by hepatocytes, conjugated, and excreted into bile.
Measures uptake + conjugation + excretion.
High retention of BSP at 45 minutes → indicates hepatocellular dysfunction.
Seen in:
Cirrhosis
Chronic hepatitis
Drug-induced liver injury
(Not used in modern practice but remains viva favorite.)
Liver converts ammonia → urea.
Failure of metabolism → ↑ ammonia.
Acute liver failure
Hepatic encephalopathy
Severe hepatocellular dysfunction
Portosystemic shunts
Evaluates microsomal enzyme — cytochrome P450 activity.
Low CO₂ excretion after aminopyrine load = impaired P450 activity.
(Advanced test, rarely used but conceptually important.)
These tests measure how well the liver synthesizes essential proteins, coagulation factors, and lipids.
Reflects chronic liver disease (long half-life ~21 days)
Unchanged in acute hepatitis
Cirrhosis
Chronic hepatitis
Nephrotic syndrome
Malnutrition
Liver synthesizes clotting factors II, VII, IX, X.
Acute liver failure
Cholestasis (vitamin K malabsorption)
Severe hepatocellular injury
Vitamin K deficiency
Warfarin therapy
PT is the best indicator of acute liver synthetic function.
Low cholesterol: chronic liver disease, advanced cirrhosis
High cholesterol: obstructive jaundice (impaired excretion)
Synthesized in liver; levels correlate with synthetic capacity.
Chronic liver disease
Cirrhosis
Hepatocellular failure
Malnutrition
Used clinically in:
Organophosphate poisoning (to assess recovery)
Liver produces:
Fibrinogen
Prothrombin
Factors V, VII, IX, X
Very specific marker:
→ Reduced only in liver disease, NOT in vitamin K deficiency.
Galactose tolerance test, fructose clearance, BSP test → test metabolic detoxification.
Serum ammonia rises in hepatic encephalopathy.
Albumin reflects chronic liver disease.
PT/INR is the most sensitive marker of acute liver synthetic failure.
Pseudocholinesterase falls in chronic liver disease.
Low cholesterol → end-stage liver disease; high cholesterol → obstructive jaundice.
Liver diseases are best interpreted by knowing which enzyme pattern corresponds to hepatocellular damage, cholestasis, or infiltrative disease.
More specific for liver.
Very high in acute viral hepatitis.
Moderately elevated in alcoholic liver disease, fatty liver.
Found in liver, muscle, heart, kidney.
High in alcoholic hepatitis (AST:ALT > 2).
Also high in muscle injury (important for differential).
2 → Alcoholic hepatitis
<1 → Viral hepatitis
Very high in obstructive jaundice.
Also high in bone disease → confirm with GGT.
High in:
Obstruction
Alcoholic liver disease
Enzyme induction (drugs: phenytoin)
Used to differentiate hepatic ALP from bone ALP.
Specific for cholestasis
Increases parallel to ALP but not elevated in bone disorders.
LDH-5 rises in hepatic necrosis.
LDH-1 > LDH-2 is seen in MI (not liver).
Mitochondrial enzyme
Elevated in severe hepatocellular injury, especially alcoholic hepatitis.
Synthesized in liver
Low in chronic liver disease, malnutrition, cirrhosis.
| Pattern | Likely Diagnosis |
|---|---|
| ALT, AST very high (>1000) | Acute viral hepatitis, ischemic injury |
| ALP + GGT very high | Obstructive jaundice |
| AST > ALT (ratio >2) | Alcoholic hepatitis |
| Low albumin + prolonged PT | Chronic liver failure |
| High bilirubin + high ALP | Cholestasis |
| High unconjugated bilirubin | Hemolysis |
These tests evaluate acid secretion, parietal cell function, and gastrin levels.
Measure gastric acid secretion in fasting state
Aspirate gastric contents over 1 hour using Ryle’s tube
Expressed as mEq/hour
1–5 mEq/hour
Zollinger–Ellison syndrome
Gastrinoma
Hyperparathyroidism
Achlorhydria
Pernicious anemia
Chronic atrophic gastritis
Measure acid output after pentagastrin stimulation.
Represents maximal parietal cell capacity.
MAO very high → gastrinoma
MAO low → pernicious anemia, gastric atrophy
Gastrinoma
Normal individuals
Pernicious anemia
Use Hollander test, diagnostic caffeine test, or dye recovery test to determine presence of acid without gastric intubation.
Screening for achlorhydria
Monitoring pernicious anemia patients
(Less commonly used today.)
Zollinger–Ellison syndrome (gastrinoma)
Atrophic gastritis
Pernicious anemia
PPI therapy
Acid hypersecretion due to feedback inhibition
Tests parietal cell function and HCl secretion.
Diagnosis of achlorhydria vs hypochlorhydria
Distinguish pernicious anemia (no response) from gastritis (partial response)
HCl secretion is tested to evaluate parietal cell activity and conditions altering acid levels.
Measures fasting acid secretion.
After pentagastrin stimulation.
Highest amount secreted after stimulation.
Measures pH using titration against NaOH.
Zollinger–Ellison syndrome (gastrinoma)
Duodenal ulcers
Hyperparathyroidism
Massive vagal stimulation
G cell hyperfunction
Achlorhydria
Pernicious anemia
Chronic atrophic gastritis
Gastric carcinoma
Vagotomy
PPI therapy (omeprazole)
BAO = 0
MAO = 0
Serum gastrin very high
Parietal cell antibodies present
ALP and GGT together = best markers of cholestasis.
AST:ALT >2 → alcoholic liver disease.
ALT > AST → viral hepatitis.
Absence of HCl = achlorhydria (pernicious anemia).
High BAO + high MAO + very high gastrin = gastrinoma.
Normal BAO + low MAO = parietal cell loss (atrophic gastritis).
Gastric acidity is measured from gastric juice obtained via Ryle’s tube after fasting.
Amount of free HCl present in gastric juice (not bound to proteins).
Gastric juice is titrated with 0.1 N NaOH
Indicator: Topfer’s reagent
Changes color when free HCl is neutralized
Free acidity: 20–40 mEq/L
Increased in:
Zollinger–Ellison syndrome
Duodenal ulcer
G-cell hyperfunction
Hyperparathyroidism
Decreased/Absent in:
Pernicious anemia (achlorhydria)
Chronic atrophic gastritis
Gastric carcinoma
Long-term PPI therapy
Sum of:
Free HCl
Combined HCl
Other acids (organic acids)
Continue titration beyond Topfer endpoint
Use phenolphthalein indicator
Neutralizes total acid content
Total acidity: 40–70 mEq/L
Increased in acid hypersecretion states
Decreased in achlorhydria
| Condition | BAO | MAO | Interpretation |
|---|---|---|---|
| Achlorhydria | 0 | 0 | No acid even after stimulation |
| Hypochlorhydria | Low | Moderate | Reduced, but responds to stimulation |
Seen in:
Pernicious anemia (complete achlorhydria)
Gastric atrophy
Gastric carcinoma
Diagnosis of achlorhydria
Evaluation of gastrinoma (high BAO/MAO)
Differentiating pernicious anemia vs chronic gastritis
Monitoring post-vagotomy or PPI therapy
Pancreatic tests assess enzyme secretion, bicarbonate secretion, and exocrine function.
(Most accurate but invasive)
Gold standard for exocrine pancreatic function.
Secretin → stimulates bicarbonate secretion
CCK/pancreozymin → stimulates enzyme secretion
Duodenal contents aspirated & measured
Low bicarbonate + low enzymes → chronic pancreatitis
Normal values → excludes major pancreatic disease
Stimulates pancreas by giving a standard meal.
Low trypsin/chymotrypsin in aspirate → pancreatic insufficiency
(Non-invasive, used clinically)
Acute pancreatitis
Pancreatic duct obstruction
Perforated ulcer
Salivary gland disease
Returns to normal within 2–3 days
Not specific for pancreas
More specific for pancreas
Remains elevated longer (7–10 days)
Acute pancreatitis
Pancreatic necrosis
Detects fat malabsorption due to lack of pancreatic enzymes.
7 g/day of fat in stool indicates steatorrhea
Seen in:
Chronic pancreatitis
Cystic fibrosis
Pancreatic carcinoma
200 µg/g stool → normal
100–200 → mild insufficiency
<100 → severe exocrine insufficiency
Used widely to diagnose:
Chronic pancreatitis
Cystic fibrosis
Severe chronic pancreatitis
Cystic fibrosis
Patient consumes 100 g fat/day
7 g/day fat in stool → steatorrhea
Seen in severe pancreatic insufficiency
Detects:
Pancreatic calcifications (chronic pancreatitis)
Necrosis
Mass lesions
Evaluates pancreatic ducts.
Most sensitive for early chronic pancreatitis.
| Test | Measures | Increased In | Decreased In |
|---|---|---|---|
| Serum amylase | Amylase | Acute pancreatitis | — |
| Serum lipase | Lipase | Acute pancreatitis | — |
| Fecal elastase | Pancreatic enzymes | — | Chronic pancreatitis |
| Serum trypsinogen | Exocrine function | Acute pancreatitis | Chronic pancreatitis |
| Secretin test | Bicarbonate output | — | Pancreatic insufficiency |
| Stool fat test | Fat malabsorption | Steatorrhea | — |
Lipase > amylase for diagnosing acute pancreatitis.
Fecal elastase-1 is the best non-invasive test for chronic pancreatitis.
Secretin-Pancreozymin test is the gold standard for exocrine pancreatic function.
Achlorhydria shows zero free and total acidity.
Gastrinoma → very high BAO & MAO + high gastrin.
ALT predominantly comes from hepatocytes; AST is also from muscle and heart.
ALP ↑ (also in bone disease)
GGT ↑ (confirm hepatic origin; also ↑ in alcohol intake)
Direct bilirubin ↑
Liver function otherwise normal
Amylase often normal
Fecal elastase ↓
Fat malabsorption ↑
ALT ↑↑
AST ↑↑
Bilirubin ↑
ALP mild ↑
AST > ALT (ratio > 2)
GGT ↑
ALP ↑↑
GGT ↑↑
Direct bilirubin ↑
Pale stool
Indirect bilirubin ↑
Urine bilirubin absent
Urobilinogen ↑
Albumin ↓
PT ↑
Cholesterol ↓
A. AST
B. ALT
C. ALP
D. GGT
Answer: B. ALT
A. Viral hepatitis
B. Alcoholic hepatitis
C. Obstructive jaundice
D. Cirrhosis only
Answer: B. Alcoholic hepatitis
A. AST
B. ALT
C. ALP + GGT
D. LDH
Answer: C. ALP + GGT
A. Albumin
B. Serum bilirubin
C. PT/INR
D. ALP
Answer: C. PT/INR
A. Acute hepatocellular injury
B. Chronic liver disease
C. Degree of cholestasis
D. Gallstone obstruction
Answer: B. Chronic liver disease
A. Obstruction
B. Hemolysis
C. Dubin–Johnson syndrome
D. Rotor syndrome
Answer: B. Hemolysis
A. Hemolysis
B. Pernicious anemia
C. Obstructive jaundice
D. Gilbert syndrome
Answer: C. Obstructive jaundice
A. Hemolysis
B. Gilbert syndrome
C. Obstructive jaundice
D. No liver disease
Answer: C. Obstructive jaundice
A. Viral hepatitis
B. Hemolysis
C. Obstructive jaundice
D. Gilbert syndrome
Answer: C. Obstructive jaundice
A. Hemolysis
B. Hepatic jaundice
C. Obstruction of bile ducts
D. Dubin–Johnson syndrome
Answer: C. Obstruction
A. Cholic acid and chenodeoxycholic acid
B. Lithocholic and deoxycholic acid
C. Taurocholate only
D. Glycocholate only
Answer: A
A. Serine
B. Taurine and glycine
C. Tryptophan
D. Alanine
Answer: B
A. Increased unconjugated bilirubin
B. Black liver pigmentation
C. Absent bile salts
D. Increased urobilinogen
Answer: B
A. Serum lipase
B. Serum amylase
C. Fecal elastase-1
D. Serum trypsinogen
Answer: C. Fecal elastase-1
A. AST
B. Amylase
C. Lipase
D. LDH
Answer: C. Lipase
A. Gastrinoma
B. Steatorrhea
C. Achlorhydria
D. Bile acid malabsorption
Answer: B. Steatorrhea
A. Secretin–pancreozymin test
B. Serum lipase
C. Fecal fat test
D. Serum amylase
Answer: A
A. Zollinger–Ellison syndrome
B. Pernicious anemia
C. Duodenal ulcer
D. Hyperparathyroidism
Answer: B. Pernicious anemia
A. Low BAO
B. High BAO and MAO
C. Absent BAO
D. No change in acid output
Answer: B
A. Phenolphthalein
B. Topfer’s reagent
C. Methyl red
D. Congo red
Answer: B
A. Topfer’s reagent
B. Bromothymol blue
C. Phenolphthalein
D. Ninhydrin
Answer: C
A. Hollander test
B. Secretin test
C. Pentagastrin stimulation test
D. Glucose tolerance test
Answer: C
A. Liver
B. Stomach
C. Gallbladder
D. Colon
Answer: C
A. GGT
B. Lipase
C. Pseudocholinesterase
D. ALP
Answer: C
A. Acute pancreatitis
B. Chronic pancreatitis
C. Obstructive jaundice
D. Hemolysis
Answer: B
A. ALT
B. AST
C. GGT
D. LDH
Answer: C
A. Gastrinoma
B. Pernicious anemia
C. Duodenal ulcer
D. Chronic pancreatitis
Answer: B
A. Hepatic jaundice
B. Obstructive jaundice
C. Hemolytic jaundice
D. Dubin–Johnson syndrome
Answer: C
A. Pancreatic enzymes
B. Bicarbonate-rich pancreatic juice
C. Bile salts
D. Gastric HCl
Answer: B
A. Serum amylase
B. Abdominal X-ray
C. Endoscopic ultrasound (EUS)
D. Serum bilirubin
Answer: C
Total bilirubin: 9 mg/dL
Direct bilirubin: 6 mg/dL
ALP: ↑↑
GGT: ↑↑
Urine bilirubin: Present
Stool: Pale
Most likely diagnosis?
(Conjugated hyperbilirubinemia + high ALP/GGT + dark urine + pale stools)
What is the diagnosis?
(AST > ALT, ratio > 2 with GGT elevation)
Total bilirubin: 15 mg/dL
Indirect bilirubin: 14 mg/dL
No bilirubin in urine
What type of jaundice?
What is the most probable cause?
(Cholestasis + fat malabsorption + pruritus + high ALP/GGT)
Diagnosis?
Albumin ↓
PT prolonged
AST/ALT mildly raised
Cholesterol ↓
What does this indicate?
(Low synthetic function + low cholesterol)
Serum amylase: 1200 IU/L
Serum lipase: 2600 IU/L
Hypocalcemia
Diagnosis?
(Lipase > amylase + typical clinical picture)
Fecal fat: 20 g/day
Fecal elastase-1: 70 µg/g stool
Serum trypsinogen: Low
Cause?
Serum gastrin is markedly elevated.
Diagnosis?
Serum gastrin is very high.
Diagnosis?
Direct bilirubin ↑
ALP ↑↑
GGT ↑↑
Urobilinogen absent
What is the biochemical explanation?
Indirect bilirubin ↑
Urine bilirubin absent
Urine urobilinogen ↑↑
Type of jaundice?
Stool fat: 15 g/day.
Fecal elastase: 80 µg/g.
Diagnosis?
Gastric pH > 4
BAO ↓
Serum gastrin ↑
What does this indicate?
ALT ↑↑
AST ↑↑
Direct bilirubin moderately ↑
Indirect bilirubin ↑
ALP normal
Diagnosis?
PT prolonged
Albumin low
Bilirubin high
ALT moderately raised
Which is the best indicator of severity?
Serum bilirubin is slightly increased.
What is the next best test?
Free acidity: 0
Total acidity: 0
After pentagastrin: still 0
Serum intrinsic factor antibodies present
Diagnosis?
Low serum amylase
Low serum lipase
Fatty stools
Fecal elastase 90 µg/g
Diagnosis?
ALT
Alcoholic hepatitis
Acute viral hepatitis or ischemic injury
ALP and GGT
Because GGT rises only in liver disease, not in bone disorders.
Serum albumin (long half-life)
PT/INR
Conjugated bilirubin only
Hemolysis, Gilbert syndrome, Crigler–Najjar
Obstruction, hepatocellular disease, Dubin–Johnson
High indirect bilirubin + high urobilinogen + no urine bilirubin
High direct bilirubin + high ALP/GGT + pale stool + dark urine
Lack of stercobilinogen.
Conjugated bilirubin cannot reach the intestine.
Black liver due to pigment accumulation.
Conjugated hyperbilirubinemia with normal liver histology
Cholic and chenodeoxycholic acid
Deoxycholic and lithocholic acid
Glycine or taurine
Fat emulsification and micelle formation
Basal acid output (fasting HCl secretion)
Zollinger–Ellison syndrome
Maximum acid output after stimulation (usually pentagastrin)
Absence of free HCl.
Pernicious anemia, atrophic gastritis
Usually >0.6
Parietal cell function and HCl secretion
Topfer’s reagent
Phenolphthalein
20–40 mEq/L
40–70 mEq/L
Peptic ulcer disease, gastrinoma
Lipase
Amylase
Lipase (7–10 days)
Fecal elastase-1
Secretin–pancreozymin test
Steatorrhea
Chronic pancreatitis, cystic fibrosis, pancreatic cancer
Chronic pancreatitis, cystic fibrosis
Vitamin K absorption ↓ → ↓ clotting factors.
Backpressure in bile canaliculi → increased ALP synthesis.
It is bound to albumin and water-insoluble.
Excess conjugated bilirubin excreted in urine.
Retention of bile salts in blood.
Loss of acid → loss of negative feedback → gastrin ↑.
Gastric outlet obstruction or retained acid.
Pancreatic tissue is burnt out, unable to release enzymes.
Get the full PDF version of this chapter.